Literature DB >> 25785977

Why is there no generic insulin? Historical origins of a modern problem.

Jeremy A Greene1, Kevin R Riggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25785977     DOI： 10.1056/NEJMms1411398

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Premixed insulin regimens in type 2 diabetes: pros.

Authors:  Maria Ida Maiorino; Giuseppe Bellastella; Katherine Esposito; Dario Giugliano
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633

2.  Tertiary patenting on drug-device combination products in the United States.

Authors:  Reed F Beall; Aaron S Kesselheim
Journal:  Nat Biotechnol       Date:  2018-02-06       Impact factor: 54.908

3.  Biosimilar Insulin and Costs: What Can We Expect?

Authors:  Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2015-09-08

Review 4.  Why Are Diabetes Medications So Expensive and What Can Be Done to Control Their Cost?

Authors:  Laura N McEwen; Sarah Stark Casagrande; Shihchen Kuo; William H Herman
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

5.  The High Cost-related Medication Non-adherence Rate Among Medicare-Medicaid Dual-Eligible Diabetes Patients.

Authors:  James X Zhang; David O Meltzer
Journal:  J Health Med Econ       Date:  2016-02-25

6.  Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018.

Authors:  Inmaculada Hernandez; Chester B Good; William H Shrank; Walid F Gellad
Journal:  JAMA       Date:  2019-04-23       Impact factor: 56.272

Review 7.  Controlled release of biologics for the treatment of type 2 diabetes.

Authors:  Caslin A Gilroy; Kelli M Luginbuhl; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2015-12-02       Impact factor: 9.776

8.  Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.

Authors:  Xinyang Hua; Natalie Carvalho; Michelle Tew; Elbert S Huang; William H Herman; Philip Clarke
Journal:  JAMA       Date:  2016-04-05       Impact factor: 56.272

Review 9.  Origins of the Crisis in Insulin Affordability and Practical Advice for Clinicians on Using Human Insulin.

Authors:  Jing Luo; Walid F Gellad
Journal:  Curr Diab Rep       Date:  2020-01-29       Impact factor: 5.430

10.  A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison.

Authors:  Ananta Addala; Marie Auzanneau; Kellee Miller; Werner Maier; Nicole Foster; Thomas Kapellen; Ashby Walker; Joachim Rosenbauer; David M Maahs; Reinhard W Holl
Journal:  Diabetes Care       Date:  2020-09-16       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.